300406.SZ
300406.SZ
CNE100001Y26
BSBE
Loading chart...

Company Profile

Beijing Strong Biotechnologies,Inc. researches, develops, manufactures, and sells in-vitro diagnostics (IVD) products and services in China and internationally. It provides biochemistry reagents, including liver, renal, lipid, cardiac, diabetes, special protein, tumor marker, pancreas, inorganic, inflammation, TDM, and other panels; and coagulation products, such as prothrombin time, activated partial thromboplastin time, thrombin time, and fibrinogen, as well as antithrombin III, von Willebrand factor antigen, protein S activity, protein C, lupus anticoagulant, fibrin degradation products, and d-dimer. The company also offers blood grouping card comprising ABO blood type anti stereotype detection card, DiaClon ABD-confirmation, and DiaClon ABO/D+ reverse grouping for patients; and automatic coagulation analyzer, automatic biochemistry analyzer, fully automatic chemiluminescence immunoassay analyzer, and automated blood groupings analyzer. It sells its products under the Kingsley and Meichuang brand names. Beijing Strong Biotechnologies,Inc. was founded in 2001 and is based in Beijing, China.

Related stocks

300685.SZ
300685.SZ • China
AMOYDX
20.3 CNY
1.18B USD 1Y -11.6%
300463.SZ
300463.SZ • China
MAKER BIOTECHNOLOGY
9.58 CNY
866.78M USD 1Y -17%
603108.SS
603108.SS • China
SHANGHAI RUNDA MEDICAL TECHNOLO
9.97 CNY
901.98M USD 1Y -36.5%
603882.SS
603882.SS • China
GUANGZHOU KINGMED DIAGNOSTICS G
28.82 CNY
2B USD 1Y -3.4%
4544.T
4544.T • Japan
H.U. GROUP HLDGS INC
3,580 JPY
1.23B USD 1Y -4%
METROPOLIS.NS
METROPOLIS.NS • India
METROPOLIS HEALTHCARE LTD
529.25 INR
1.13B USD 1Y +4.2%
300244.SZ
300244.SZ • China
D.A. DIAGNOSTICS
20.4 CNY
1.91B USD 1Y +24.4%
4694.T
4694.T • Japan
BML INC
3,650 JPY
864.57M USD 1Y +1.2%

Key Metrics & Overview

Detailed metrics & financial data of the company

Company Profile
5 Metrics

🛡️ Risk & Structural Analysis

Multi-Factor Risk Model & Market Data

7/7 Very High
5Y Volatility
40.2% p.a.
Max Drawdown (5Y)
-57.1%
Sharpe Ratio (5Y)
-0.23
Beta Factor
0.27
Size Class
Mid Cap
Notes & Warnings
Single Stock Risk: Investing in an individual stock carries full company and insolvency risk (no fund diversification).
Exemplary balance sheet strength: Very solid ratio of equity to debt.
🔴 Low analyst coverage – higher uncertainty in growth estimates & projections
Structurally High Volatility: Above-average fluctuations persist across 5 to 10 years (40.2% p.a.).
Historical Stress Test: Maximum peak-to-trough drawdown of -63.6% in the extended horizon.
ende